Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

Ireland, 25 pages report, published by GlobalData

Keywords : Merrion Pharmaceuticals Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Report ThumbnailOctober-2016
Summary

Merrion Pharmaceuticals Plc (Merrion) is a pharmaceutical company that offers prescription pharmaceutical products to meet unmet needs in healthcare. The company’s product pipeline includes Orazol breast cancer, Orazol bone metastases, Almerol (MER-103), Acyline (MER-104) and MER-102. It offers its products in drug forms such as tablets, capsules and injections. Merrion’s products are used to treat therapeutic areas suuh as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has agreements with several pharmaceutical companies. Merrion is headquartered in Dublin, Ireland.

Merrion Pharmaceuticals Plc Key Recent Developments

Feb 03, 2016: Merrion Pharmaceuticals Announces Directorate Change
Jun 30, 2015: Merrion Pharmaceuticals announces Annual Reports

This comprehensive SWOT profile of Merrion Pharmaceuticals Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Merrion Pharmaceuticals Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • List of Figures
  • Merrion Pharmaceuticals Plc, Performance Chart
  • Merrion Pharmaceuticals Plc, Ratio Charts
  • List of Tables
  • Merrion Pharmaceuticals Plc, Key Information
  • Merrion Pharmaceuticals Plc, Key Ratios
  • Merrion Pharmaceuticals Plc, Share Data
  • Merrion Pharmaceuticals Plc, Major Products and Services
  • Merrion Pharmaceuticals Plc, History
  • Merrion Pharmaceuticals Plc, Key Employees
  • Merrion Pharmaceuticals Plc, Key Employee Biographies
  • Merrion Pharmaceuticals Plc, Key Operational Heads
  • Merrion Pharmaceuticals Plc, Other Locations
  • Merrion Pharmaceuticals Plc, Subsidiaries
  • Merrion Pharmaceuticals Plc, Key Manufacturing facilities
  • Merrion Pharmaceuticals Plc, Key Competitors
  • Merrion Pharmaceuticals Plc, SWOT Analysis
  • Merrion Pharmaceuticals Plc, Ratios based on current share price
  • Merrion Pharmaceuticals Plc, Annual Ratios
  • Merrion Pharmaceuticals Plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • Table of Contents
  • Section 1 - About the Company
  • Merrion Pharmaceuticals Plc - Key Information
  • Merrion Pharmaceuticals Plc - Overview
  • Merrion Pharmaceuticals Plc - Key Employees
  • Merrion Pharmaceuticals Plc - Key Employee Biographies
  • Merrion Pharmaceuticals Plc - Key Operational Heads
  • Merrion Pharmaceuticals Plc - Major Products and Services
  • Merrion Pharmaceuticals Plc - History
  • Merrion Pharmaceuticals Plc - Company Statement
  • Merrion Pharmaceuticals Plc - Locations And Subsidiaries
  • Merrion Pharmaceuticals Plc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Merrion Pharmaceuticals Plc - Business Description
  • Merrion Pharmaceuticals Plc - Corporate Strategy
  • Merrion Pharmaceuticals Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Merrion Pharmaceuticals Plc - Strengths
  • Merrion Pharmaceuticals Plc - Weaknesses
  • Merrion Pharmaceuticals Plc - Opportunities
  • Merrion Pharmaceuticals Plc - Threats
  • Merrion Pharmaceuticals Plc - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Merrion Pharmaceuticals Plc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company

Please select a license type

Share

Related Products

GlobalDataMerrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailMerrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review, Company Report available for $300Product #: 45246
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved